Share
a week ago
AstraZeneca to invest $2.5bn in China after scandal
a week ago
AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing
Tags: manfacturing, scandal, AstraZeneca, drugs research, Beijing, China,
Enter your email to subscribe to news alerts
Subscribe
←Top Latest Headlines